Efficacy and Tolerability of Candesartan Cilexetil in Special Patient Groups

Area of Science:

• Cardiology
• Pharmacology
• Nephrology

Background:

• Hypertension is a heterogeneous condition requiring antihypertensive therapies that are effective and well-tolerated.
• Therapies should ideally mitigate hypertension's target-organ damage, including atherosclerosis, cardiovascular remodeling, and renal impairment.

Purpose of the Study:

• To evaluate the efficacy and tolerability of candesartan cilexetil in various patient populations.
• To assess its impact on specific conditions like severe hypertension, diabetes mellitus, pulmonary disease, and heart failure.
• To determine its effects on hypertension-related target-organ damage, such as left ventricular hypertrophy and microalbuminuria.

Main Methods:

• Review of accumulating evidence from clinical studies and large trials.
• Assessment of blood pressure control in diverse patient groups, including women and the elderly.
• Evaluation of tolerability and side effect profiles compared to other antihypertensive agents.
• Analysis of effects on glucose tolerance, lipid profiles, and specific organ damage markers.

Main Results:

• Candesartan cilexetil effectively lowers blood pressure and is well-tolerated in women, the elderly, and patients with severe hypertension.
• In severe hypertension, combination therapy with candesartan cilexetil, diuretics, and calcium antagonists successfully controlled blood pressure.
• The drug does not adversely affect glucose tolerance or lipid profiles in diabetic patients and is suitable for those with pulmonary disease.
• Initial studies show good tolerability and efficacy in heart failure patients.
• Treatment reversed negative effects of hypertension on left ventricular hypertrophy and microalbuminuria.

Conclusions:

• Candesartan cilexetil demonstrates pronounced efficacy and placebo-like tolerability in mild to moderate hypertension.
• Its benefits extend to a wide range of specific patient groups, including those with severe hypertension, heart failure, and diabetes.
• The drug effectively manages blood pressure and reverses target-organ damage associated with hypertension.